A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial
Clinical trial NCT06141811 · RECRUITING
Trial details
- NCT number
- NCT06141811
- Sponsor
- Anterogen Co., Ltd.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-25
- Primary completion
- 2025-12-31
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.